Effects of dehydroepiandrosterone and alprazolam on hypothalamic-pituitary responses to exercise

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 8, 2005, Pages 4777-4783

  Deuster, Patricia A ^a   Faraday, Martha M ^a   Chrousos, George P ^c   Poth, Merrily A ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ARGIPRESSIN; CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; PRASTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DYNAMIC EXERCISE; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; ALPRAZOLAM; ARGININE VASOPRESSIN; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; EXERCISE; GABA MODULATORS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GABA-A;

EID: 23844550562     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2504     Document Type: Article

References (38)

1. Mellon SH, Vaudry H 2001 Biosynthesis of neurosteroids and regulation of their synthesis. Int Rev Neurobiol 46:33-78
2. Kudielka BM, Hellhammer J, Hellhammer DH, Wolf OT, Pirke KM, Varadi E, Pilz J, Kirschbaum C 1998 Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. J Clin Endocrinol Metab 83:1756-1761
3. Baulieu EE 1998 Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987
4. Browne ES, Wright BE, Porter JR, Svec F 1992 Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 303:366-371
5. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J 1998 Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852-1857
6. Deuster PA, Petrides JS, Singh A, Chrousos GP, Poth M 2000 Endocrine response to high-intensity exercise: dose-dependent effects of dexamethasone. J Clin Endocrinol Metab 85:1066-1073
7. Petrides JS, Gold PW, Mueller GP, Singh A, Stratakis C, Chrousos GP, Deuster PA 1997 Marked differences in functioning of the hypothalamic-pituitary- adrenal axis between groups of men. J Appl Physiol 82:1979-1988
8. Arvat E, Giordano R, Grottoli S, Ghigo E 2002 Benzodiazepines and anterior pituitary function. J Endocrinol Invest 25:735-747
9. Balogera AE, Gallucci WT, Chrousos GP, Gold PW 1988 Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin releasing hormone secretion in vitro. Brain Res 463:28-36
10. Cavagnini F, Invitti C, Pinto M, Maraschini C, Di Landro A, Dubini A, Marelli A 1980 Effect of acute and repeated administration of γ aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endocrinol (Copenh) 93:149-154
11. Chiodera P, Volpi R, Maffei ML, Caiazza S, Caffarri G, Papadia C, Alfano L, Pagani D, Coiro V 1993 Role of GABA and opioids in the regulation of the vasopressin response to physical exercise in normal men. Regul Pept 49:57-63
12. Coiro V, Volpi R, Capretti L, Colla R, Chiodera P 1994 Opioid modulation of the γ-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men. Eur J Endocrinol 131:50-55
13. Herman JP, Mueller NK, Figueiredo H 2004 Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration. Ann NY Acad Sci 1018:35-45
14. Otake K, Kondo K, Oslo Y 1991 Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by γ-aminobutyric acid in conscious rats. Neuroendocrinology 54:170-174
15. Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E 1998 Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans. Neuroendocrinology 67:310-316
16. Giordano R, Grottoli S, Brossa P, Pellegrino M, Destefanis S, Lanfranco F, Gianotti L, Ghigo E, Arvat E 2003 Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf) 59:314-320
17. Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E 2002 The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans. J Clin Endocrinol Metab 87:4616-4620
18. Grottoli S, Arvat E, Gauna C, Maccagno B, Ramunni J, Giordano R, Maccario M, Deghenghi R, Ghigo E 2000 Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. Int J Obes Relat Metab Disord 24(Suppl 2):S136-S137
19. Kalogeras KT, Calogero AE, Kuribayiashi T, Khan I, Gallucci WT, Kling MA, Chrousos GP, Gold PW 1990 In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 70:1462-1471
20. Risby ED, Hsiao JK, Golden RN, Potter WZ 1989 Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects. Psychopharmacology (Berl) 99:508-514
21. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV 1993 Alpraxolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. J Clin Endocrinol Metab 76:388-391
22. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV 1994 Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropinreleasing hormone in humans. J Clin Endocrinol Metab 79:140-144
23. Kyle, SB, Smoak BS, Douglass LW, Deuster PA 1989 Variability of responses across training levels to maximal treadmill exercise. J Appl Physiol 67:160-165
24. Rittmaster RS, Cutler GB, Gold PW, Brandon DD, Tomai T, Loriaux DL, Chrousos GP 1987 The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone stimulated adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab 64:371-376
25. Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E 2002 Interactions between GABAergic and aminoacidergic pathways in the control of gonadotropin and GH secretion in pre-pubertal female rats. J Endocrinol Invest 25:96-100
26. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP 1987 Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise: physiologic adaptations to physical training. N Engl J Med 316:1309-1315
27. Luger A, Watschinger B, Deuster P, Svoboda T, Clodi M, Chrousos GP 1992 Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion. Neuroendocrinology 56:112-117
28. Smoak B, Deuster P, Rabin D, Chrousos GP 1991 Corticotropin-releasing hormone is not the sole factor mediating exercise-induced adrenocorticotropin release in humans. J Clin Endocrinol Metab 73:302-306
29. Demirgoren S, Majewska MD, Spivak CE, London ED 1991 Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45:127-135
30. Wen S, Dong K, Onolfo JP, Vincens M 2001 Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex. Eur J Pharmacol 430:373-374
31. Bergeron R, de Montigny C, Debonnel G 1996 Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16:1193-1202
32. Yamaguchi K, Watanabe K 2002 Contribution of N-methyl-D-aspartate receptors in the anteroventral third ventricular region to vasopressin secretion, but not to cardiovascular responses provoked by hyperosmolality and prostaglandin E2 in conscious rats. Brain Res Bull 58:301-309
33. Rossi NF, Chen H 2002 Modulation of ET(B) receptor-induced arginine-vasopressin secretion by N-methyl-D-aspartate (NMDA) and γ-aminobutyric acid (GABA)-dependent mechanisms in hypothalamo- neurohypophysial explants. Clin Sci (Lond) 103(Suppl 48):162S-166S
34. Orlowska-Majdak M, Traczyk WZ, Szymanski D 2003 Hippocampal vasopressin release evoked by N-methyl D-aspartate (NMDA) microdialysis. Physiol Res 52:373-382
35. Kitamura T, Mishina M, Sugiyama H 2003 Enhancement of neurogenesis by running wheel exercises is suppressed in mice lacking NMDA receptor ε1 subunit. Neurosci Res 47:55-63
36. Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E 2002 Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. J Endocrinol Invest 25:420-425
37. Rohrer T, von Richthofen V, Schulz C, Beyer J, Lehnert H 1994 The stress- but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. Horm Metab Res 26:200-206
38. Kroboth PD, Salek FS, Stone RA, Bertz RJ, Kroboth 3rd FJ 1999 Alprazolam increases dehydroepiandrosterone concentrations. J Clin Psychopharmacol 19:114-124